rFVIIaFc

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamerFVIIaFc

Drug Alias Namerecombinant factor VIIa Fc fusion protein (Biogen Idec)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionFactor VIIa agonists

TargetsCoagulation factor VII

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiogen Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiogen Inc

Active IndicationsN/A

Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A